PF-07242813

N/A

Report date: 2022/12/27 15:49:22
NME

Base Information

Drug NamePF-07242813
Drug Alias NamePF-07242813
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCD1d antigens inhibitors
TargetsCD1d antigens
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Inc
Inactive CompaniesN/A
Active IndicationsDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A